Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic statins as a possible method to decrease bubble formation in diving.

Christopher A Duplessis1, David Fothergill, Derek Schwaller

  • 1Naval Submarine Medical Research Laboratory, Groton, CT 06349-5900, USA.

Aviation, Space, and Environmental Medicine
|May 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.

PloS one·2025
Same author

Response to "Hospital Staffing and Hospital Harm Trends Throughout the COVID-19 Pandemic" by Campbell et al. (2024).

Healthcare quarterly (Toronto, Ont.)·2024
Same author

The Differential Translation Capabilities of the Human DHFR2 Gene Indicates a Developmental and Tissue-Specific Endogenous Protein of Low Abundance.

Molecular & cellular proteomics : MCP·2024
Same author

Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers.

Open forum infectious diseases·2022
Same author

Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.

Emerging infectious diseases·2022
Same author

Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers.

Open forum infectious diseases·2022

Atorvastatin did not reduce bubble formation in divers, despite lowering cholesterol. Further research is needed to understand why statins may not prevent decompression sickness.

Area of Science:

  • Diving Medicine
  • Pharmacology
  • Cardiovascular Research

Background:

  • Nitric oxide (NO) may reduce bubble formation during diving.
  • Statins are potential agents to increase NO and improve vascular function.
  • Statin-induced lipid reduction might decrease bubble generation by altering plasma surface tension.

Purpose of the Study:

  • To investigate the efficacy of atorvastatin in reducing bubble formation after diving.
  • To assess atorvastatin as a pharmacological intervention for decompression sickness (DCS).

Main Methods:

  • 16 military divers underwent a hyperbaric chamber dive protocol.
  • Divers received either 80-mg atorvastatin or placebo for 4 days, followed by the alternate regimen after a 2-week washout.
  • Post-dive, trans-thoracic echocardiography assessed bubble grades, analyzed using Wilcoxon signed-rank tests.

Related Experiment Videos

Main Results:

  • No significant difference in maximum bubble grade scores was observed between atorvastatin and placebo.
  • Atorvastatin significantly reduced low-density lipoprotein (LDL) and total cholesterol (TC) levels.
  • Factors like age, bioelectrical impedance, TC, LDL, potassium, and calcium correlated with bubble grades in the placebo group.

Conclusions:

  • Four days of prophylactic 80-mg atorvastatin did not decrease intravascular bubbles post-dive.
  • Potential reasons for failure include differential vascular effects, lack of improved endothelial function, or limitations of the bubble grading system.
  • Statins may not be an effective prophylactic measure against bubble formation in divers.